Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREDNOS 2
2012-003476-39Phase 3Unknown
- Sponsor
- University of Birmingham
- Start
- Nov 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of prednisolone in nephrosis (2 arms), sponsored by University of Birmingham. Primary endpoint: First URTI-related relapse of nephrotic syndrome during 12-month follow-up. Status: unknown.
02
Drugs
prednisolone
03
Conditions
nephrosis
Beyond the preview
Go deeper on 2012-003476-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003476-39.